Sjogren's syndrome

Clinical Otolaryngology and Allied Sciences

Volumn 25, Issue 5, 2000, Pages 350-357

  Sood, Sanjai ^a,b   Anthony, R ^a   Pease, C T ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; AUTOANTIBODY; CORTICOSTEROID; CYCLOSPORIN; GLANDOSANE; HYDROXYPROPYLCELLULOSE; IMMUNOSUPPRESSIVE AGENT; LUBORANT; PILOCARPINE; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN; ROSE BENGAL; SALIVA SUBSTITUTE;

BLOOD ANALYSIS; CANCER RISK; CLINICAL FEATURE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; KERATOCONJUNCTIVITIS SICCA; LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND EXAMINATION; SALIVARY GLAND SCINTISCANNING; SCHIRMER TEST; SJOEGREN SYNDROME; TREATMENT OUTCOME; XEROSTOMIA; PATHOPHYSIOLOGY;

HUMANS; SJOGREN'S SYNDROME;

EID: 0034297093     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2000.00412.x     Document Type: Review

References (75)

1. Zur kenntnis der keratoconjunctivitis sicca. Keratitis filiformis bei hypofunction der tranendrusen
2. Insuffisance progressive et atrophie des glandes salivaires et muqueuses de la bouche, des conjonctives (et parfois des musqueuses nasale, laryngee, vulvaire) secheresse de la bouche, des conjuntives, etc.
3. Preliminary criteria for the classification of Sjogren's syndrome: Results of a prospective concerted action supported by the European community
4. Sjogren's syndrome: A clinical, pathological and serological study of sixty-two cases
5. Dry Eye
6. Primary Sjogren's syndrome: Diagnostic criteria, clinical features and disease activity
7. The oral component of Sjogren's syndrome
8. The prevalence of Sjogren's syndrome in a close rural community
9. Dry eyes or mouth: An epidemiological study in Swedish adults, with special reference to primary Sjogren's syndrome
10. Prevalence of primary Sjogren's syndrome in an elderly population
11. Clinical features, pathogenesis, and treatment of Sjogren's syndrome
12. Aberrant expression pattern of the SS-B antigen in the labial salivary glands of patients with Sjogren's syndrome
13. The etiopathogenesis of Sjogren's syndrome
14. Sjogren's syndrome: Close to cause and cure?
15. The natural history of benign lymphoepithelial lesion of the salivary gland in which there is a monoclonal population of B cells
16. Mucosa associated lymphoid tissue lymphomas
17. Gynecologic manifestations of Sjogren's syndrome
18. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome
19. Serological and immunogenetic markers of extraglandular primary Sjogren's Syndrome
20. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus
21. Epstein Barr virus and the lacrimal gland pathology of Sjogren's syndrome
22. Elevated levels of soluble Fc epsilon R11/CD23 and antibodies to Epstein Barr Virus in patients with Sjogren's syndrome
23. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome
24. Detection of Epstein-Barr virus in salivary gland specimens from. Sjogren's syndrome patients
25. Antibody to cytomegalovirus in patients with Sjogren's Syndrome: As determined by an enzyme-linked immunosorbent assay
26. Primary Sjogren's syndrome: The challenge for classification of disease manifestations
27. Salivary mucins in oral mucosal defence
28. Aging and saliva: A review of the literature
29. Increased risk of lymphoma in sicca syndrome
30. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome
31. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses
32. Predictors of lymphoma development in primary Sjogren's syndrome
33. Advances in the diagnosis and concept of Sjogren's syndrome (autoimmune exocrinopathy)
34. Correlation of labial salivary gland biopsies with ocular and oral findings in patients with Sjogren's syndrome
35. Vasculitis in primary Sjogren's syndrome: Histologic classification and clinical presentation
36. Sjogren's syndrome with acute renal failure
37. Immune mediated inner ear disease: Report of clinical cases
38. Clinical evaluation of 117 patients with Sjogren's syndrome
39. Peripheral neuropathy associated with sicca complex
40. Central nervous system disease in primary Sjogren's syndrome
41. Sjogren's syndrome: Controversies and progress
42. Hepatitis-C virus and Sjogren's syndrome
43. Primary salivary gland amyloidosis causing sicca syndrome
44. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca: Analysis of 618 patients with suspected Sjogren's syndrome
45. Natural history of HIV-associated salivary gland disease
46. Periductal lymphocytic infiltration of salivary glands in Sjogren's syndrome with relation to clinical and immunologic findings
47. Primary Sjogren's syndrome: Clinical and laboratory markers of disease activity
48. Diagnostic tests in the sicca syndrome
49. Tear fluid proteins in Sjogren's syndrome
50. Tear function parameters in keratoconjunctivitis sicca with and without the association of Sjogren's syndrome
51. A comparative study between tear protein electrophoresis and accessory salivary gland biopsy in Sjogren's syndrome
52. The use of whole saliva in the differential diagnosis of Sjoren's syndrome
53. Major salivary gland function in primary Sjogren's syndrome and its relationship to clinical features
54. Subjective reports of xerostomia and objective measures of salivary gland performance
55. Relationship between sialographic findings of parotid glands and histopathologic finding of labial glands in Sjogren's syndrome. Relation to clinical and immunologic findings
56. Salivary gland scinitigraphy in subjects with and without symptoms of dry mouth and/or eyes, and in patients with primary Sjogren's syndrome
57. Magnetic resonance imaging of the parotid glands and lip biopsy in the evaluation of xerostomia in Sjogren's syndrome
58. Sjoegren's syndrome: MR imaging of the parotid gland
59. MR sialography in patients with Sjogren syndrome
60. Utility and safety of parotid gland biopsy in Sjogren's syndrome
61. Labial salivary gland biopsy in Sjogren's syndrome: Assessment as a diagnostic criterion in 362 suspected cases
62. Labial salivary gland biopsy is Sjogren's disease
63. Early detection of lymphomas in Sjogren's syndrome by in situ hybridisation for κ and γ light chain mRNA in labial salivary glands
64. Sjogren's syndrome: Proposed criteria for classification
65. Criteria for Sjogren's syndrome in Japan
66. Criteria for diagnosis of Sjogren's syndrome
67. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study
68. The European classification criteria for Sjogren's syndrome (SS): Proposal for a modification of the rules for classification suggested by the analysis of the receiver operating characteristics (ROC) curve of the criteria performance
69. Sjogren's syndrome: Controversies and progress
70. The clinical picture of primary Sjogren's syndrome: A retrospective study
71. Keratoconjunctivitis sicca in patients with primary Sjogren's syndrome: A longitudinal study of ocular parameters
72. Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sjogren's syndrome
73. The use of slow release artificial tears in the long-term management of keratitis sicca
74. Topical cyclosporin treatment of keratoconjuntivitis sicca in secondary Sjogren's syndrome
75. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia)